Advanced PET scans reveal that late-life depression and bipolar disorder may signal early neurodegenerative changes before dementia symptoms emerge.
Key Details
- 1Study involved 52 late-life mood disorder (LLMD) patients and 47 controls using PET imaging for tau and amyloid proteins.
- 2~50% of LLMD patients showed abnormal tau accumulation vs. 15% of controls; 29% had amyloid vs. 2% of controls.
- 3Autopsy of 208 brain cases confirmed higher tau-related pathologies in those with late-life mood symptoms.
- 4Pathological protein buildup detectable an average of 7.3 years before cognitive or motor symptoms.
- 5Study used two PET tracers to capture diverse tau and amyloid pathologies.
- 6Findings support tau-PET as a tool for early detection of neurodegenerative diseases in psychiatric populations.
Why It Matters
These findings advance the role of molecular PET imaging in diagnosing neurodegenerative diseases at the preclinical stage—especially in patients with mood disorders—enabling earlier interventions and reshaping the clinical approach to late-onset psychiatric presentations.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.